Patrick J. Heron, Director, 10% Owner at MBX Biosciences, Inc. (MBX), bought 4,552,774 shares at $16.00 ($10.0M) on 2024-09-16, disclosed to the SEC on 2024-09-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,927,774 | $0 | 0.0% |
| 2 | $16.00 | 625,000 | $10.0M | 100.0% |
| Total | $2.20 avg | 4,552,774 | $10.0M | 100% |
| Filing → |
| ARQT | BUY | 2025-06-06 | $30K | — | Filing → |
| ARQT | BUY | 2025-05-23 | $69K | — | Filing → |
| ARQT | BUY | 2025-05-19 | $34K | — | Filing → |